1Roberts WL,Moulton L,Law TC,et al.Evaluation of nine auaomated high-sensitivity C-reactive protein methods:implication for clinical and epidemiological applications.Part2.[J].Clin Chem,2001,47(3):418-425. 被引量：1
2Auer J,Berent R,Lassnig E,et al.C-creative protein and coronary artery disease[J].Jpn Heart J,2002,43(6):607-619. 被引量：1
4Yamashita H,Shimada K,Seki E,et al.Concentrations of interleukins,interferon and c-reactive protein in stable and unstable angina pectoris[J].Am J Cardiol,2003,91(2):133-136. 被引量：1
5Eriksson M,Egberg N,Wainala S,et al.Rerlationship between plasma fibrinogen and coronary heart disease in women[J].Arterioscler Thromb Vasc Biol,1999,19(7):67-72. 被引量：1
6Biasucci LM,CDC,AHA.CDC/AHA Workshop on Mardwes of Inflammation and Cardiovascular disease:Application to Clinical and Public Health Practice.Clinical use of inflammatory markers in patients with cardiovascular disease:a background paper[J].Circulation,2004,110(25):e560-e567. 被引量：1
7Loukas M,Dabrowski M,Wagner T,et al.Fibrinogen and smooth muscle cell detection in atherosclerotic plaques from stable and unstable angina immunohistochemical study[J].Med Sci Monit,2002,8(4):BR144-BR148. 被引量：1
8Tousoulis D,Dawies G,Stefanadis T,et al.Inflammatory and thrombotic mechanisms in coronary atherosclerosis[J].Heart,2003,89(9):993-997. 被引量：1
2Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women[ J ]. Circulation, 1998, 98 (8) :731 - 733. 被引量：1
3Canale ML, Stroppa S, Caravelli P, et al. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation [ J ]. Coron Artery Dis, 2006, 17(8) :693 -698. 被引量：1
4Yip HK, Hang CL, Fang CY, et al. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention [ J ]. Chest, 2005, 127(3) :803 -808. 被引量：1
5Bichel C, Rupprecht H J, Blankenberg S, et al. Relation of markers of inflammation ( C-reactive protein, fibrinogen, yon Willebrand factor and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease [ J ]. Am J Cardiol, 2002, 89(8) :901 -908. 被引量：1
6Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology [ J ]. Circulation, 2003, 107 (3) :370 -372. 被引量：1
7Matsushita K, Yatsuya H, Tamakoshi K, et al. High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk [J]. Circ J, 2007, 71(6) :820 -825. 被引量：1
8Sander K, Horn CS, Briesenick C, et al. High-sensitivity C-reactive protein is independently associated with early carotid artery progression in women but not in men: the INVADE Study [ J]. Stroke, 2007, 38 ( 11 ) :2881 - 2886. 被引量：1
9Woloshin S, Schwartz LM, Kerin K, et al. Estimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United States[J]. J Gen Intern Med, 2007,22(2) :197 -204. 被引量：1
10Bogavac-Stanojevic N, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, et al. Lipid and inflammatory markers for the prediction of coronary artery disease: a multi-marker approach [ J ]. Clin Biochem, 2007, 40(13 -14) :1000-1006. 被引量：1
